A former IDF medic now working as Moderna’s chief scientist hailed the US drug company’s progress in the race for a Covid-19 vaccine.
Dr Tal Zaks spoke to BBC News on Monday after Moderna announced that early data appears to show a 94.5 percent effectiveness rate against Covid-19.
The company, like competitor Pfizer Inc, which recently announced similar results, is expected to apply for emergency-use authorisation from the Food and Drug Administration.
"The overall effectiveness has been remarkable,” Dr Zaks told the broadcaster. “It's a great day.”
Dr Zaks, who studied at Ben Gurion University of the Negev, now lives in Massachusetts in the US.
He previously spoke about the “first-rate” training he received in Israel and referred to his experience in the IDF, according to Jewish-American news website The Algemeiner.
